Literature DB >> 8556996

Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients.

F K Pühringer1, K S Khuenl-Brady, G Mitterschiffthaler.   

Abstract

The duration of action and recovery of 0.6 mg kg-1 rocuronium in underweight, normal weight, overweight and obese patients were investigated. Forty-eight patients were divided into four groups, according to their body mass index, and were given 0.6 mg kg-1 rocuronium. The onset time, the duration 25% and either the spontaneous or induced recovery were measured according to the random assignment. The onset time in the obese group was shorter 60 (50-90) s compared to the other groups (underweight: 95 (40-320) s, normal: 95 (50-200) s, overweight: 90 (50-260) s, but the difference did not reach the level of statistical significance. The duration 25% was slightly prolonged in the obese patients (31.5 (21.0-61.0) min) when compared to the underweight (25.0 (15.0-37.0) min), normal weight (26.0 (20.0-36.0) min) and overweight (27.0 (19.0-35.0) min) patients. No differences were observed in spontaneous (9.5-12.5 min) and induced (2.5-3.5 min) recovery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8556996

Source DB:  PubMed          Journal:  Eur J Anaesthesiol Suppl        ISSN: 0952-1941


  7 in total

Review 1.  Effects of obesity on pharmacokinetics implications for drug therapy.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Anesthetic Pharmacology and the Morbidly Obese Patient.

Authors:  Jerry Ingrande; Hendrikus Jm Lemmens
Journal:  Curr Anesthesiol Rep       Date:  2012-12-13

3.  The relationship of the anthropometric variables to the infusion rate of rocuronium in the elderly.

Authors:  Bon Nyeo Koo; Sun Jun Bai; Yang-Sik Shin; Woo Chang Lee
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

4.  Relationship between the muscle relaxation effect and body muscle mass measured using bioelectrical impedance analysis: A nonrandomized controlled trial.

Authors:  Yoon-Ji Choi; Yun Hee Kim; Go Eun Bae; Joon Ho Yu; Seung Zhoo Yoon; Hee Won Kang; Kuen Su Lee; Jae-Hwan Kim; Yoon-Sook Lee
Journal:  J Int Med Res       Date:  2019-02-05       Impact factor: 1.671

Review 5.  A review on the anesthetic management of obese patients undergoing surgery.

Authors:  Rimanatou Seyni-Boureima; Zongze Zhang; Malyn M L K Antoine; Chrystal D Antoine-Frank
Journal:  BMC Anesthesiol       Date:  2022-04-05       Impact factor: 2.217

6.  Does Rocuroinum Dose Adjusted Due to Lean Body Weight Provide Adequate Intubation Conditions?: A Prospective Observational Study.

Authors:  Duygu Demiroz; Yusuf Ziya Colak; Sumeyye Koc Iclek; Mehmet Ali Erdogan; Neslihan Altunkaya Yagci; Mahmut Durmus; Nurcın Gulhas
Journal:  Int J Clin Pract       Date:  2022-10-05       Impact factor: 3.149

7.  Comparison of the effect of rocuronium dosing based on corrected or lean body weight on rapid sequence induction and neuromuscular blockade duration in obese female patients.

Authors:  Bahar Sakızcı-Uyar; Seref Çelik; Aysun Postacı; Yeşim Bayraktar; Bayazit Dikmen; Işıl Özkoçak-Turan; Ozlem Saçan
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.